(Q44115525)

reason for preferred rank

29 November 2017

Clofibrate-lnduced acute muscular syndrome (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9149(72)90053-7

13 April 2023

Clofibrate-induced acute muscular syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5073673

Cardiology and cardiovascular medicine

13 April 2023

main subject

1 reference

https://api.crossref.org/works/10.1016/0002-9149(72)90053-7

13 April 2023

author name string

I. Sekowski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5073673

13 April 2023

P. Samuel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5073673

13 April 2023

language of work or name

English

0 references

publication date

1 October 1972

1 reference

full work available at URL

29 November 2017

https://api.elsevier.com/content/article/PII:0002914972900537?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9149(72)90053-7

https://api.elsevier.com/content/article/PII:0002914972900537?httpAccept=text/plain

13 April 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9149(72)90053-7

American Journal of Cardiology

13 April 2023

published in

1 reference

29 November 2017

30

1 reference

29 November 2017

572-574

1 reference

29 November 2017

5

1 reference

Clofibrate and androsterone effect on serum lipids

29 November 2017

3

1 reference

https://api.crossref.org/works/10.1016/0002-9149(72)90053-7

Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements

13 April 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9149(72)90053-7

EFFECT OF ATROMID ON REQUIREMENTS OF WARFARIN

13 April 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9149(72)90053-7

THE EFFECTS OF ATROMID ON SERUM LIPIDS, PROTEINS AND SOME LIVER FUNCTION TESTS IN HYPERCHOLESTEROLAEMIC PATIENTS.

13 April 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9149(72)90053-7

Acute Muscular Syndrome Associated with Administration of Clofibrate

13 April 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9149(72)90053-7

Reduction of serum-lipid and uric-acid levels by an orally active androsterone

13 April 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9149(72)90053-7

Clofibrate-induced ventricular arrhythmia

13 April 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9149(72)90053-7

Long-term effects of clofibrate (Atromid-S) on serum lipids in man

13 April 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9149(72)90053-7

Clofibrate, Serum Enzymes, and Muscle Pain

13 April 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9149(72)90053-7

An improved procedure for serum creatine phosphokinase determination

13 April 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9149(72)90053-7

SERUM CREATINE PHOSPHOKINASE (CPK) ACTIVITY IN DISORDERS OF HEART AND SKELETAL MUSCLE

13 April 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9149(72)90053-7

Creatine phosphokinase in disease

13 April 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9149(72)90053-7

Creatin kinase in human tissues.

13 April 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9149(72)90053-7

13 April 2023

Identifiers

1 reference

29 November 2017

1 reference